Industry News

Teva Reaches Settlement in ProAir HFA Patent Case
Ruvo Center: We are not meeting the challenge of curing Alzheimer's disease
Pharma companies on a talent hunt to fill skills gap [India Business]
FDA Classifies ConvaTec's Voluntary Global Recall of Flexi-Seal Control Fecal Management System (FMS) as Class I
St. Jude Medical Resolves FDA Warning Letter for Sylmar Facility
FDA Approves Updated Labeling for Gattex� (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data
NutriGold's Fish Oil Supplement IFOS 5-star Certified and ConsumerLab Approved
Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE� Antibody Blinatumomab In Acute Lymphoblastic Leukemia Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer
Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE Antibody Blinatumomab In Acute Lymphoblastic Leukemia Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer
Glaxo And Theravance Submits Supplemental NDA For Breo Ellipta
Glaxo and Theravance Submit Supplemental NDA For Breo Ellipta
FSC Laboratories, Inc. to Market AcipHex Sprinkle (rabeprazole sodium) in the U.S.
FDA Approves Updated Labeling for Gattex� (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data
FDA Approves Updated Labeling for Gattex� (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
GSK and Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma
AJMC Review of Specialty Pharmaceuticals Finds New Drugs Prove Their Value
FSC Laboratories, Inc. to Market AcipHex� Sprinkle� (rabeprazole sodium) in the U.S.
Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund for Triferic(TM) NDA
GSK and Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma
FSC Laboratories, Inc. to Market AcipHex� Sprinkle� (rabeprazole sodium) in the U.S.
Actavis Confirms Generic Zubsolv� Patent Challenge
FDA Approves Orphan Drug Designation for Pharmaceutical Cannabidiol
RedHill Biopharma Acquires Phase II Oncology Drug MESUPRON(R) From WILEX AG
Flamel Technologies Announces FDA Approval of VAZCULEP